sucrose has been researched along with Hemorrhage in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Ay, Y; Cubukcu, D; Gozmen, S; Karapinar, TH; Oymak, Y; Toret, E; Vergin, RC | 1 |
| Beckmann, H; Hou, Q; Hu, Y; Sun, J; Wu, J; Wu, R; Xiao, J; Yang, R; Zhao, Y | 1 |
| Bonanad, S; Bosch, P; Cid, AR; Haya, S; Marqués, MR; Megías-Vericat, JE; Monte-Boquet, E; Pérez-Alenda, S; Poveda, JL; Querol, F | 1 |
| Gercheva, L; Ghinea, M; Goranov, S; Hong, W; Kempton, CL; Lissitchkov, T; Manco-Johnson, MJ; Reding, MT; Rescia, V; Rusen, L; Uscatescu, V | 1 |
| Delesen, H; Enriquez, MM; Lalezari, S; Martinowitz, U; Scharrer, I; Schwartz, L; Windyga, J | 1 |
| Andreeva, TA; Khametova, RN; Plyushch, OP; Spira, J | 1 |
| Konigs, C; von Hentig, N | 1 |
| Di Minno, G; Hellmann, A; Ingerslev, J; Maas Enriquez, M; Martinowitz, U; Pabinger, I; Powell, J; Schwartz, L; Windyga, J | 1 |
| Shi, J; Sun, J; Wang, L; Wu, J; Yang, R; Zhao, Y | 1 |
| Powell, JS | 1 |
| Faradji, A; Gorina, E; Ingerslev, J; Iorio, A; Lambert, T; Maas-Enriquez, M; Musso, R; Santagostino, E; van der Meer, J | 1 |
| Frampton, JE; Wagstaff, AJ | 1 |
| Ishihara, H; Iwakawa, T; Sakai, I; Suzuki, A; Takamura, K | 1 |
| Abshire, TC; Brackmann, HH; Gazengel, C; Gorina, E; Hoots, K; Kellermann, E; Powell, JS; Scharrer, I; Vosburgh, E | 1 |
| Fukutake, K; Shima, M; Shirahata, A; Takamatsu, J; Yoshioka, A | 2 |
| Biagioli, EC; Biagiotti, R; Gambi, B; Martelli, E; Pezzati, M; Rubaltelli, FF | 1 |
| Anderson, WG; Hazon, N; Takei, Y | 1 |
| Brooks, CC; Miyahara, AY; Nakamura, RM | 1 |
| Dalderup, LM; Visser, W | 1 |
| Dumkin, IM | 1 |
| Amer, S; Hayasidani, H; Hikosaka, K; Hirota, Y; Kang, CB; Koge, K; Koyama, Y; Motobu, M; Nakamura, K; Sameshima, T; Yamada, M | 1 |
2 review(s) available for sucrose and Hemorrhage
| Article | Year |
|---|---|
A review of current literature on second-generation, sucrose-formulated, full-length recombinant factor VIII.
Topics: Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Excipients; Factor VIII; Hemophilia A; Hemorrhage; Humans; Sucrose | 2009 |
Sucrose-formulated octocog alfa: a review of its use in patients with haemophilia A.
Topics: Blood Loss, Surgical; Chemistry, Pharmaceutical; Coagulants; Excipients; Factor VIII; Hemophilia A; Hemorrhage; Humans; Sucrose; Treatment Outcome | 2008 |
9 trial(s) available for sucrose and Hemorrhage
| Article | Year |
|---|---|
Efficacy of standard prophylaxis versus on-demand treatment with bayer's sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with severe hemophilia A.
Topics: Adolescent; Asian People; Child; Child, Preschool; China; Factor VIII; Female; Follow-Up Studies; Hemophilia A; Hemorrhage; Humans; Male; Sucrose; Time Factors | 2017 |
Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART).
Topics: Adolescent; Adult; Drug Administration Schedule; Factor VIII; Hemophilia A; Hemorrhage; Humans; International Cooperation; Magnetic Resonance Imaging; Male; Middle Aged; Quality of Life; Sucrose; Treatment Outcome; Young Adult | 2013 |
Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Coagulation Tests; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Factor VIII; Hemophilia A; Hemorrhage; Humans; Male; Middle Aged; Premedication; Severity of Illness Index; Sucrose; Treatment Outcome; von Willebrand Factor; Young Adult | 2014 |
Evaluation of liposomal dose in recombinant factor VIII reconstituted with pegylated liposomes for the treatment of patients with severe haemophilia A.
Topics: Adult; Cross-Over Studies; Factor VIII; Hemophilia A; Hemorrhage; Humans; Liposomes; Male; Middle Aged; Models, Genetic; Polyethylene Glycols; Safety; Sucrose; Time Factors; Treatment Outcome | 2008 |
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study.
Topics: Adolescent; Adult; Chemistry, Pharmaceutical; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Factor VIII; Hemophilia A; Hemorrhage; Humans; Liposomes; Male; Middle Aged; Polyethylene Glycols; Solvents; Sucrose; Treatment Outcome; Young Adult | 2012 |
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting.
Topics: Adolescent; Adult; Blood Coagulation Factor Inhibitors; Blood Loss, Surgical; Chemistry, Pharmaceutical; Child; Child, Preschool; Coagulants; Europe; Excipients; Factor VIII; Hemophilia A; Hemorrhage; Humans; Infant; Infusions, Parenteral; Male; Product Surveillance, Postmarketing; Prospective Studies; Recombinant Proteins; Severity of Illness Index; Sucrose; Time Factors; Treatment Outcome | 2008 |
Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group.
Topics: Adolescent; Adult; Antibodies; Child; Cross-Over Studies; Drug Compounding; Drug Evaluation; Factor VIII; Hemophilia A; Hemorrhage; Home Infusion Therapy; Humans; Male; Middle Aged; Partial Thromboplastin Time; Patient Satisfaction; Recombinant Proteins; Sucrose; Time Factors; Treatment Outcome | 2000 |
Pharmacokinetics, prophylactic effects, and safety of a new recombinant FVIII formulated with sucrose (BAY 14-2222) in Japanese patients with hemophilia A.
Topics: Adolescent; Adult; Child; Consumer Product Safety; Drug Evaluation; Factor VIII; Half-Life; Hemophilia A; Hemorrhage; Humans; Japan; Male; Middle Aged; Recombinant Proteins; Sucrose | 2000 |
Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan.
Topics: Adolescent; Adult; Child; Cohort Studies; Consumer Product Safety; Drug Combinations; Factor VIII; Hemophilia A; Hemorrhage; Hemostasis; Humans; Isoantibodies; Japan; Longitudinal Studies; Middle Aged; Recombinant Proteins; Sucrose; Therapeutic Equivalency | 2001 |
11 other study(ies) available for sucrose and Hemorrhage
| Article | Year |
|---|---|
Which tests can most effectively indicate the clinical phenotype of paediatric haemophilia patients with prophylaxis?
Topics: Adolescent; Blood Coagulation Tests; Child; Factor VIII; Hemophilia A; Hemorrhage; Humans; Sucrose; Thrombelastography; Thrombin | 2021 |
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate
Topics: Adolescent; Adult; Child; Cross-Sectional Studies; Drug Compounding; Factor VIII; Female; Hemophilia A; Hemorrhage; Humans; Middle Aged; Sucrose; Treatment Outcome; Young Adult | 2019 |
Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China.
Topics: Adolescent; Adult; Child; China; Drug Evaluation; Factor VIII; Hemophilia A; Hemorrhage; Humans; Middle Aged; Risk Factors; Sucrose | 2007 |
Liposomal approach towards the development of a longer-acting factor VIII.
Topics: Animals; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Factor VIII; Hemorrhage; Hemostasis; Humans; Liposomes; Mice; Models, Animal; Random Allocation; Sucrose; Treatment Outcome | 2007 |
Measurements of extracellular fluid volume in highly perfused organs and lung water in hypo- and hypervolaemic dogs.
Topics: Animals; Blood Glucose; Blood Pressure; Body Fluids; Cardiac Output; Central Venous Pressure; Dogs; Edema; Extracellular Space; Extravascular Lung Water; Female; Glucose; Heart Rate; Hemorrhage; Indicator Dilution Techniques; Isotonic Solutions; Linear Models; Male; Pulmonary Wedge Pressure; Ringer's Lactate; Sucrose; Tissue Distribution | 1998 |
Umbilical cord care: the effect of eight different cord-care regimens on cord separation time and other outcomes.
Topics: Bacitracin; Benzoyl Peroxide; Coloring Agents; Delivery, Obstetric; Hemorrhage; Humans; Infant Mortality; Infant, Newborn; Neomycin; Patient Compliance; Patient Satisfaction; Prospective Studies; Rosaniline Dyes; Salicylic Acid; Sepsis; Silver; Sucrose | 2002 |
Osmotic and volaemic effects on drinking rate in elasmobranch fish.
Topics: Animals; Blood Chemical Analysis; Blood Physiological Phenomena; Drinking Behavior; Elasmobranchii; Female; Hemorrhage; Hydrogen-Ion Concentration; Male; Osmolar Concentration; Seawater; Sodium Chloride; Species Specificity; Sucrose | 2002 |
Effect of menadione and other factors on sugar-induced heart lesions and hemorrhagic syndrome in the pig.
Topics: Animals; Chlortetracycline; Dietary Carbohydrates; Female; Glucose; Heart Diseases; Hemorrhage; Male; Prothrombin Time; Rats; Salicylates; Sucrose; Swine; Swine Diseases; Syndrome; Vitamin K | 1973 |
Influence of extra sucrose, fats, protein and of cyclamate in the daily food on the life-span of rats.
Topics: Adrenal Gland Diseases; Adrenal Glands; Animals; Body Weight; Bread; Butter; Cyclamates; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Glomerulonephritis; Hemorrhage; Infarction; Kidney; Liver; Longevity; Male; Meat; Necrosis; Organ Size; Pancreas; Rats; Sucrose; Testis; Vegetables | 1971 |
[The use of blood preserved by the mass dilution method in surgical practice].
Topics: Adolescent; Adult; Aged; Blood Preservation; Blood Transfusion; Bromides; Child; Child, Preschool; Citrates; Dehydration; Ethanol; Glucose; Hemorrhage; Humans; Hypoproteinemia; Middle Aged; Nitrofurazone; Plasma Substitutes; Postoperative Care; Protein Hydrolysates; Shock, Surgical; Shock, Traumatic; Sodium Chloride; Solutions; Sucrose; Sulfacetamide; Surgical Procedures, Operative | 1966 |
Protective effects of sugar cane extract on endotoxic shock in mice.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythrocytes; Female; Galactosamine; Hemorrhage; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Saccharum; Salmonella; Shock, Septic; Tumor Necrosis Factor-alpha | 2006 |